UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of report (Date of the earliest event reported) May 717, 2012

SRI/SURGICAL EXPRESS, INC.

(Exact Name of Registrant as specified in ~~its~~ Charter)

Florida

001-34953

59-3252632

(State or Other Jurisdiction

of Incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

12425 Race Track Road

Tampa, Florida 33626

(Address of Principal Executive Offices)

(813) 891-9550

(Registrant’s Telephone Number, Including Area Code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 25.0207. ~~Results~~Submission of ~~Operations~~Matters ~~and~~to ~~Financial~~a ~~Condition~~Vote of Security Holders.

OnAt ~~May 7,~~the ~~2012,~~Annual Meeting of Shareholders of SRI/Surgical Express, Inc. ~~issued~~(the a“Company”) ~~press~~held ~~release~~on ~~announcing~~May 17, ~~its~~2012, ~~results~~the ofshareholders ~~operations~~elected ~~for~~James ~~the~~T. ~~quarter~~Boosales ~~ended~~and ~~March 31,~~Charles ~~2012~~T. AOrsatti ~~copy~~as directors of the ~~this~~Company ~~press~~to ~~release~~serve isuntil ~~attached~~the as2015 ~~Exhibit 99~~Annual Meeting of Shareholders.1 toThe final voting results in this ~~Form~~election ~~8-K.~~were as follows:

The information furnished herein, including Exhibit 99.1, is not deemed to be “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section. This information will not be deemed to be incorporated by reference into any filing under the Securities Act or the Exchange Act, except to the extent that the registrant specifically incorporates it by reference.


Director	Votes For		Votes Against or Withheld		Abstentions		Broker Non-Votes

James T. Boosales		1,559,702		3,086,325		-0-		1,232,869
Charles T. Orsatti		2,143,182		2,502,845		-0-		1,232,869

~~Item~~James 9M.01 Emanuel, Charles W. ~~Financial~~Federico, ~~Statements~~Michael D. Israel, Wayne R. Peterson, and ~~Exhibits~~Gerald Woodard continue to serve as directors of the Company.

~~(c)~~Shareholders ~~Exhibits~~also ratified the appointment of Grant Thornton LLP as the Company’s independent auditors. The final voting results were as follows:

99.1 Press Release dated May 7, 2012


	Votes For		Votes Against		Abstentions		Broker Non-Votes

Ratification of Grant Thornton LLP		5,807,008		71,039		849		-0-

Signature

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunder duly authorized.

	~~SRI/SURGICAL EXPRESS, INC.~~	SRI/SURGICAL EXPRESS, INC.
	~~(Registrant)~~	(Registrant)
Dated: May 7, 2012	By:	/s/ Mark R. Faris
Dated: May 18, 2012		By:	/s/ Mark R. Faris
		~~Mark R. Faris~~	Mark R. Faris
		Vice President and Chief Financial Officer
			Chief Financial Officer

EXHIBIT INDEX

ExhibitNumber		Description
99.1		Press Release dated May 7, 2012.

Filing Compare · SRI SURGICAL EXPRESS INC